Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes

Abstract Background The activity and haemolytic toxicity associated with primaquine has been linked to its reactive metabolites. The reactive metabolites are thought to be primarily formed through the action of cytochrome P450-mediated pathways. Human erythrocytes generally are not considered a sign...

Full description

Bibliographic Details
Main Authors: Pius S. Fasinu, N. P. Dhammika Nanayakkara, Yan-Hong Wang, Narayan D. Chaurasiya, H. M. Bandara Herath, James D. McChesney, Bharathi Avula, Ikhlas Khan, Babu L. Tekwani, Larry A. Walker
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Malaria Journal
Online Access:http://link.springer.com/article/10.1186/s12936-019-2658-5
_version_ 1818912945903501312
author Pius S. Fasinu
N. P. Dhammika Nanayakkara
Yan-Hong Wang
Narayan D. Chaurasiya
H. M. Bandara Herath
James D. McChesney
Bharathi Avula
Ikhlas Khan
Babu L. Tekwani
Larry A. Walker
author_facet Pius S. Fasinu
N. P. Dhammika Nanayakkara
Yan-Hong Wang
Narayan D. Chaurasiya
H. M. Bandara Herath
James D. McChesney
Bharathi Avula
Ikhlas Khan
Babu L. Tekwani
Larry A. Walker
author_sort Pius S. Fasinu
collection DOAJ
description Abstract Background The activity and haemolytic toxicity associated with primaquine has been linked to its reactive metabolites. The reactive metabolites are thought to be primarily formed through the action of cytochrome P450-mediated pathways. Human erythrocytes generally are not considered a significant contributor to drug biotransformation. As erythrocytes are the target of primaquine toxicity, the ability of erythrocytes to mediate the formation of reactive oxidative primaquine metabolites in the absence of hepatic enzymes, was evaluated. Methods Primaquine and its enantiomers were incubated separately with human red blood cells and haemoglobin. Post-incubation analysis was performed with UPLC–MS/MS to identify products of biotransformation. Results The major metabolite detected was identified as primaquine-5,6-orthoquinone, reflecting the pathway yielding putative active and haematotoxic metabolites of primaquine, which was formed by oxidative demethylation of 5-hydroxyprimaquine. Incubation of primaquine with haemoglobin in a cell-free system yielded similar results. It appears that the observed biotransformation is due to non-enzymatic processes, perhaps due to reactive oxygen species (ROS) present in erythrocytes or in the haemoglobin incubates. Conclusion This study presents new evidence that primaquine-5,6-orthoquinone, the metabolite of primaquine reflecting the oxidative biotransformation pathway, is generated in erythrocytes, probably by non-enzymatic means, and may not require transport from the liver or other tissues.
first_indexed 2024-12-19T23:22:40Z
format Article
id doaj.art-bef9c2cb44b441a495645be8bf521194
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-19T23:22:40Z
publishDate 2019-01-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-bef9c2cb44b441a495645be8bf5211942022-12-21T20:01:56ZengBMCMalaria Journal1475-28752019-01-011811810.1186/s12936-019-2658-5Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytesPius S. Fasinu0N. P. Dhammika Nanayakkara1Yan-Hong Wang2Narayan D. Chaurasiya3H. M. Bandara Herath4James D. McChesney5Bharathi Avula6Ikhlas Khan7Babu L. Tekwani8Larry A. Walker9The National Center for Natural Products Research, The University of MississippiThe National Center for Natural Products Research, The University of MississippiThe National Center for Natural Products Research, The University of MississippiThe National Center for Natural Products Research, The University of MississippiThe National Center for Natural Products Research, The University of MississippiIronstone Separations, Inc.The National Center for Natural Products Research, The University of MississippiThe National Center for Natural Products Research, The University of MississippiThe National Center for Natural Products Research, The University of MississippiThe National Center for Natural Products Research, The University of MississippiAbstract Background The activity and haemolytic toxicity associated with primaquine has been linked to its reactive metabolites. The reactive metabolites are thought to be primarily formed through the action of cytochrome P450-mediated pathways. Human erythrocytes generally are not considered a significant contributor to drug biotransformation. As erythrocytes are the target of primaquine toxicity, the ability of erythrocytes to mediate the formation of reactive oxidative primaquine metabolites in the absence of hepatic enzymes, was evaluated. Methods Primaquine and its enantiomers were incubated separately with human red blood cells and haemoglobin. Post-incubation analysis was performed with UPLC–MS/MS to identify products of biotransformation. Results The major metabolite detected was identified as primaquine-5,6-orthoquinone, reflecting the pathway yielding putative active and haematotoxic metabolites of primaquine, which was formed by oxidative demethylation of 5-hydroxyprimaquine. Incubation of primaquine with haemoglobin in a cell-free system yielded similar results. It appears that the observed biotransformation is due to non-enzymatic processes, perhaps due to reactive oxygen species (ROS) present in erythrocytes or in the haemoglobin incubates. Conclusion This study presents new evidence that primaquine-5,6-orthoquinone, the metabolite of primaquine reflecting the oxidative biotransformation pathway, is generated in erythrocytes, probably by non-enzymatic means, and may not require transport from the liver or other tissues.http://link.springer.com/article/10.1186/s12936-019-2658-5
spellingShingle Pius S. Fasinu
N. P. Dhammika Nanayakkara
Yan-Hong Wang
Narayan D. Chaurasiya
H. M. Bandara Herath
James D. McChesney
Bharathi Avula
Ikhlas Khan
Babu L. Tekwani
Larry A. Walker
Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes
Malaria Journal
title Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes
title_full Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes
title_fullStr Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes
title_full_unstemmed Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes
title_short Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes
title_sort formation primaquine 5 6 orthoquinone the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes
url http://link.springer.com/article/10.1186/s12936-019-2658-5
work_keys_str_mv AT piussfasinu formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT npdhammikananayakkara formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT yanhongwang formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT narayandchaurasiya formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT hmbandaraherath formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT jamesdmcchesney formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT bharathiavula formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT ikhlaskhan formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT babultekwani formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes
AT larryawalker formationprimaquine56orthoquinonetheputativeactiveandtoxicmetaboliteofprimaquineviadirectoxidationinhumanerythrocytes